Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicityYasmina Mozo, Beatriz Ruz-Caracuel, María Isabel Benítez‐Carabante et al.|Pediatric Hematology and Oncology|2021Cited by 28
Haploidentical hematopoietic stem cell transplantation in pediatric and adolescent patients: A study of the Spanish hematopoietic stem cell transplantation group (GETH)Bárbara Ochoa-Fernández, Antonio Pérez‐Martínez, Víctor Galán‐Gómez et al.|Medicina Clínica|2022Cited by 4
Haploidentical hematopoietic stem cell transplantation in pediatric and adolescent patients: A study of the Spanish hematopoietic stem cell transplantation group (GETH)Bárbara Ochoa-Fernández, Antonio Pérez‐Martínez, Víctor Galán‐Gómez et al.|Medicina Clínica (English Edition)|2022Cited by 1